To know the usefulness of Homoeopathic medicines in the treatment of Attention Deficit Hyperactivity Disorder.

A Study on the Effectiveness of Individualized Homoeopathic Intervention in ADHD using Biomarkers & Standard Questionnaires: A single blind randomized Placebo controlled trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040728

Enrollment

Registered

2022-03-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

Intervention1: Any one Individualized/Personalised Homoeopathic Medicine at a time(Nux.vomica, Medorrhinum, Tarentula. Hispanica, Zinc. metallicum, Pulsatilla,Phosphorus, Arsenic Album, Natrum.muriati

Eligibility

Inclusion criteria

Inclusion criteria: 1. The cases between age group of 03 â?? 14 years of age 2. Both sexes 3. Confirmed to DSM- 5 diagnostic criteria for ADHD

Exclusion criteria

Exclusion criteria: 1. Cases with chronic medical conditions, 2. Congenital anomalies/Disorders, 3. Seizures or any other serious physical illness, 4. Other Co morbid psychiatric conditions, 5. Patients not willing to give consent, 6. Patients under psychoactive drugs in the past two weeks

Design outcomes

Primary

Measure	Time frame
To determine the overall improvement of the ADHD symptoms and general improvement of the patient using Homoeopathic follow up analysis/sheet after administration of the remedy.Timepoint: 1 year	—

Secondary

Measure	Time frame
Mean Difference in ADHD Rating Scale IV and Weiss functional impairment scaleTimepoint: 01 year	—

Countries

India

Contacts

Public ContactDr M Gnnanaprakasham

Vinayaka Mission Homoeopathic Medical College and Hospital

drsunnymathew59@gmail.com9448327218

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026